Peter Thiel-backed ‘unicorn’ biotech posits that stem cells are root cause of cancer
Stem CentRx posits that cancer is caused by stem cells gone awry - and is developing antibody drug conjugate therapies to help attack cancer at its root. The Peter Thiel-backed "unicorn" startup is valued at some $3 billion.